T
he Rel family of NF-B encodes important transcription factors that regulate the induction of genes involved in immunological, inflammatory, and antiapoptotic responses (1, 2) . In most resting cells, NF-B is sequestered in the cytoplasm, bound to a family of inhibitory molecules, inhibitor (I)B. Many stimuli, including lipopolysaccharide (LPS) (3) and inflammatory cytokine tumor necrosis factor (TNF) (4) , activate the NF-B signal transduction pathway and lead to the phosphorylation and degradation of IB. NF-B is then imported into the nucleus, where it activates transcription of target genes. In many cell types, the predominant NF-B species are p65.p50 and p50.p50. However, other B-DNA-binding proteins (designated as non-Rel-Bs) distinct from NF-B have been characterized. Generally, non-Rel-Bs differ from NF-B by size, immunogenicity, sensitivity to detergents, and sequence specificity to the B motif (Table 1 ).
An additional gene family known to encode proteins that also bind to the B motif is called the ZAS family (5) . ''ZAS'' describes a structural domain that contains a pair of C 2 H 2 zinc fingers, an acidic region, and a serine͞threonine-rich sequence (6) . There are three ZAS proteins, ZAS1, -2, and -3, in mammals and a distant relative, schnurri (shn), in Drosophila. The ZAS proteins have been shown to regulate transcription of genes involved in immunity, development, and metastasis (5). They have also been shown to regulate signal transduction. Schnurri associates with Mad͞Smad to modulate decapentaplegic͞ transforming growth factor ␤ signaling during embryonic development (7) . ZAS3 associates with TRAF2 to inhibit TNF-induced NF-B-dependent transactivation and JNK phosphorylation in vitro (8) .
Extensive DNA-protein interaction analyses have shown that individual ZAS domains bind specifically to B-like sequences (9, 10) . This observation has prompted several groups, including ours, to investigate whether the ZAS proteins are non-Rel-Bs. Results of antibody gel-shift assays and reporter gene assays suggest that non-Rel-Bs are related to ZAS2 and -3 (11) (12) (13) . However, another study suggests that non-Rel-B may be related to Sp1 (14) . Recently, several immortalized ZAS3 Ϫ/Ϫ preB cell lines have been established from a malignant teratoma that developed spontaneously in a ZAS3 (15) . To clarify the origin of non-Rel-B, we examine the B-binding species and show that non-Rel-B is absent in those ZAS3
Ϫ/Ϫ cells. Additionally, in keeping with our previous results, which show that ZAS3 associates with TRAF2 to inhibit NF-B activation, NF-B is constitutively expressed in ZAS3 Ϫ/Ϫ cells. Because ZAS3 can regulate B-mediated transcription and influence the activity of NF-B, this mechanism provides a checkpoint to control the reprogramming of gene expression.
Materials and Methods
Plasmids. The reporter plasmids, 3ϫB-Luc and p7ϫB, and expression constructs for p50 and p65 have been described (16, 17) . Both plasmids were used in reporter gene assays and yielded similar results. For the construction of a ZAS3 expression vector, a 5.7-kb XhoI ZAS3 cDNA fragment (nucleotides 973-6693) was inserted into the XhoI site of the expression vector pCMV-Tag2 (Stratagene). pSG-ZASC was constructed by inserting a 1.6-kb ZAS3 cDNA fragment (nucleotides 5831-7490) into the EcoRI site of the plasmid pSG424 (18) .
Antibodies. ZAS3 antisera have been described (13) . NF-B antibodies were gifts from Denis Guttridge, Ohio State University: p65 (Rockland, Gilbertsville, PA), p50 (Upstate Biotechnology, Lake Placid, NY), p52 (K-27; Santa Cruz Biotechnology), and c-Rel (N; Santa Cruz Biotechnology). Antibodies for IB␣ (C-21), p-IB␣ (B-9), hsp90, TRAF1, TRAF2, histone H1 (Santa Cruz Biotechnology), and FLAG (Sigma) were purchased.
Cell Lines and Transient Transfection Assays. Immortalized ZAS3
Ϫ/Ϫ
B1 and ZAS3
Ϫ/Ϫ B2 preB cells were previously called KRC-mIII and -mIV, respectively (15) . PreB cells were cultured in complete medium (RPMI medium 1640) containing 10% FCS and 50 M 2-mercaptoethanol. p65 suspension cells were seeded into each well of a 24-well plate and were cultured overnight in complete medium. After 24 h, reporter plasmid (250 ng), with or without ZAS3 expression plasmid, was transfected into cells by using the cationic lipid reagent DMRIE-C (2 l per well) (Invitrogen). Plasmid pCH110 (250 ng) encoding ␤-galactosidase was included to normalize transfection efficiency. pCMV-Tag2 was supplemented to yield a total plasmid concentration of 1 g in each transfection. Thirty-six hours posttransfection, LPS (10 g͞ml) was added to a subset of cells, and all cells were harvested 4 h later. For adherent cells, reporter plasmid (10 ng), p65 and p50 expression plasmids (10 ng each), ZAS3 expression plasmid (0-0.4 g), lipofectamine 2000 (2 l per well; Invitrogen), and pCMV-Tag2 (to adjust total DNA to 0.5 g) were used in each transfection. Luciferase and ␤-galactosidase activity were measured as described (15) .
Electrophoretic Mobility-Shift Assays (EMSAs), Antibody-Supershift Assays, and Immunoblot Analyses. EMSAs and antibody-supershift assays, with a 32 P-labeled probe (2 ϫ 10 4 cpm) containing a B site (underlined), 5Ј-CCGGGGGGACTTTCCGCTCCAC-3Ј, were performed as described (10) . Immunoblot analyses were performed as described (15) . The presence of equivalent protein loading was verified by protein staining of duplicated gels or by incubating duplicated protein blots with histone H1 or heatshock protein hsp90 antibodies.
Results and Discussion
ZAS3 Antisera React with a Non-Rel-B Absent in ZAS3 ؊/؊ Cells. In EMSA, nuclear extracts prepared from a standard preB cell line, 38B9, and a 32 P-B probe yielded several sequence-specific DNA-protein complexes (Fig. 1A, lane 1) . The prominent complexes were designated C1, -2, and -3. The addition of a ZAS3-antiserum but not preimmune serum to the binding reactions diminished the amount of C1 (Fig. 1 A, lanes 2 and 3) . Antibodies against p65 and p50 also altered the pattern of the DNA-protein complexes ( Fig. 1 A, lanes 4 and 5) . Likely, C2 and -3 were composed of p50.p50 and p65.p50, respectively. The specificity of the protein-DNA interaction was demonstrated by DNA competition. Unlabeled B oligonucleotides (20 ng; 100-fold excess) competed away the formation of all complexes ( Fig.  1 A, lane 7) , whereas a similar amount of Sp1 oligonucleotide was noncompetitive ( Fig. 1 A, lane 6) . Therefore, non-Rel-B is present in preB cells, in agreement with previous studies of B cell lineages (19, 20) . The data also show that non-Rel-B is immunologically related to ZAS3.
To clarify the origin of the non-Rel-B in B lymphocytes, EMSA was performed by using a genetic background where ZAS3 was knocked out by homologous recombination. ZAS3
Ϫ/Ϫ

B1 and ZAS3
Ϫ/Ϫ B2 were preB cell lines independently derived from a malignant teratoma of a RAG2
chimera mouse (15) . In EMSA, a prominent p65.p50 complex but not the C1 complex was observed from either nuclear extracts of the ZAS3 Ϫ/Ϫ cells ( Fig. 1 B and C) . Previous extensive RNA studies, including Northern blot analysis, RT-PCR, RNase protection, and in situ hybridization, had shown that ZAS3 was expressed specifically in neuronal and lymphoid tissues (6, 10, (21) (22) (23) . Therefore, the lymphoid expression, immunogenicity, and B-binding capability of ZAS3 and non-Rel-B are similar. Ϫ/Ϫ cells, NF-B-binding activity was mostly found in nuclear extracts ( Fig. 2A) . As such, LPS (10 g͞ml for 4 h), a reagent commonly used to stimulate NF-B in B cells (3), showed minimal effect. Conversely, NF-B DNA-binding activity was found in both cytoplasmic and nuclear extracts from 38B9 cells. On LPS stimulation, NF-B-binding activity from 38B9 cells was reduced to minimal levels in the cytoplasmic extracts with a concomitant increase of NF-B-binding activity in the nuclear extracts. The higher NF-B-binding activity from the nucleus of ZAS3 Ϫ/Ϫ cells was due, at least in part, to constitutive nuclear localization. Immunoblot analysis of nuclear extracts showed that the amount of p65 in ZAS3 Ϫ/Ϫ cells was 5-to 10-fold higher than in 38B9 cells (Fig. 2B ), in keeping with EMSA results. In addition, LPS (10 g͞ml for 4 h) increased the nuclear levels of p65 significantly in 38B9 cells but minimally in ZAS3 Ϫ/Ϫ cells. The constitutive expression of nuclear p65 in ZAS3 Ϫ/Ϫ cells and the induction of p65 in 38B9 cells by LPS were specific, because the amounts of p50 and histone H1 were comparable among all samples.
Reporter gene assays were performed to assess the Bmediated transcriptional competence of the preB cells. In line with the increase of B-DNA binding and nuclear p65, the B-reporter activity was 30-fold higher from ZAS3 Ϫ/Ϫ than 38B9 cells (Fig. 2C) . This observation agrees with the fact that, although all NF-B contain a Rel homology domain for DNA binding, only p65, RelB, and c-Rel contain transactivation domains (1). In addition, LPS (10 g͞ml for 4 h) augmented B-reporter activity 5-to 8-fold in 38B9 cells but minimally in ZAS3 Ϫ/Ϫ cells. The increase in NF-B binding and consequently B-mediated transcription in ZAS3 Ϫ/Ϫ cells was due, in part, to the up-regulation of nuclear p65.
The remarkable effect of ZAS3 on the B-reporter suggests that ZAS3 should have a major impact on NF-B-dependent gene expression and cell fate. Accordingly, ZAS3 had been shown to control the expression of TNF␣, an NF-B target gene, in macrophages and in an epithelial cell line (8) . Additionally, tumorogenesis and immortalization had been observed in ZAS3-deficient animals and cells, respectively (15) . In keeping with the differential expression of NF-B, immunoblot analyses showed that the amount of TRAF1 and -2, whose expression was controlled by NF-B, was higher in ZAS3 Ϫ/Ϫ cells than in 38B9 cells (Fig. 2D) .
In most cell types, NF-B associated with IB in the cytoplasm but was translocated into the nucleus when IB was degraded. To further characterize NF-B signaling in ZAS3 Ϫ/Ϫ cells, the expression and phosphorylation status of IB␣ were examined. The amount of IB␣ in unstimulated 38B9 cells was significantly higher than that of ZAS3 Ϫ/Ϫ cells (Fig. 2E ), in keeping with the constitutive expression of NF-B in the latter cells. Of interest, IB␣ was hyperphosphorylated in ZAS3 Ϫ/Ϫ
cells, suggesting an induction of IB kinase (IKK). Taken together, in ZAS3
Ϫ/Ϫ cells, the absence of ZAS3, a TRAF2 inhibitor, activates the assembly of the IKK complex. IKK phosphorylates IB, which marks IB for ubiquitination and degradation. NF-B then translocates into the nucleus, leading to activation of gene expression.
ZAS3 Directly Represses NF-B-Mediated
Transcription. ZAS3 expression was restored in ZAS3 Ϫ/Ϫ cells to demonstrate that the induction of NF-B was a consequence of ZAS3 deficiency. To this end, a 7.2-kb ZAS3 cDNA harboring the largest ORF of 2,348 residues was constructed by conventional molecular cloning procedures by using clones isolated from standard cDNA or genomic libraries. That DNA fragment, when inserted in-frame into the FLAG-tag expression plasmid pCMV-Tag2, yielded low expression in HEK 293 cells (data not shown). Subsequently, plasmids with shorter inserts were constructed, and a DNA fragment encoding amino acids 106-2013 of ZAS3, which contained all known structural features of ZAS3, yielded abundant fusion proteins (Fig. 3A) . The FLAG-ZAS3 fusion protein was detectable from nuclear but not from cytoplasmic extracts. Similar cellular distribution was observed for a nuclear protein control, histone H1. Previously, ZAS3 antibodies detected signals from the nucleus and cytoplasm (8) . The cytosolic signal might be derived from smaller ZAS3 isoforms generated by alternative splicing (22) .
Reporter gene assays initially showed that ZAS3 expression reduced the activity of B-reporter genes in HEK 293 (Fig. 3B ) and 38B9 cells (data not shown). Subsequent cotransfection experiments with ZAS3 and NF-B (p50 and p65) expression constructs showed that ZAS3 repressed NF-B-mediated transactivation of the B reporter (Fig. 3C) . Significantly, ZAS3 expression also inhibited the B reporter in ZAS3
Ϫ/Ϫ cells (Fig. 3D) , providing a link between ZAS3 deficiency and NF-B activation.
To evaluate how ZAS3 expression represses NF-Bdependent transactivation, the level of NF-B in the preB cells was examined after transient transfection with the ZAS3 expression construct by immunoblot analyses. In 38B9 cells, p65 was mainly located in the cytoplasmic extracts and was barely detected from the nuclear extracts (Fig. 4, compare lanes 1 and  5) . ZAS3 expression in 38B9 cells reduced the amount of nuclear p65 with a concomitant increase of cytoplasmic p65. On the contrary, p65 was located mainly in the nuclear extracts of ZAS3 Ϫ/Ϫ cells (Fig. 4, compare lanes 3 and 7) . Introduction of the ZAS3 expression construct in ZAS3 Ϫ/Ϫ cells resulted in a marked reduction of nuclear p65 and a corresponding increase of cytoplasmic p65. As controls for protein loading and cell fractionation, appropriate signals were observed when immunoblot analyses were performed for a nuclear protein, histone H1, or a cytosolic protein, heat-shock protein hsp90. We conclude that p65 was up-regulated in ZAS3 Ϫ/Ϫ cells, and that ZAS3 activated the nuclear export pathway of p65.
A careful inspection revealed that the gel mobility of p65 from 38B9 cells was slightly faster than that of ZAS3 Ϫ/Ϫ cells, indicating differences in posttranslational modifications. Protein modifications at specific sites, including phosphorylation and acetylation, have been shown to affect DNA binding, IB association, and transcriptional activity of p65 (24, 25) . However, incubation of the samples with shrimp alkaline phosphatases had no effect on the gel mobility of p65 (data not shown), suggesting the difference might not be due to protein phosphorylation. Previously, two such closely migrating p65-antibody reacting species were observed in immunoblot analysis of rat livers, and treatment with calf intestine alkaline phosphatases also did not resolve the difference in their gel mobility (26) .
ZAS3 Represses Transcription Independent of p65. Although p65 contains the transactivation domain, the activity of the Breporter genes was not directly proportional to the amount of p65. For example, whereas the amount of p65 in LPSstimulated 38B9 was more than that in ZAS3 Ϫ/Ϫ cells (compare Fig. 2B, lanes 2 and 4) , the B reporters were 5-fold more active in the latter (Fig. 2C ). There are several not mutually exclusive possibilities to account for this discrepancy. First, RelB and c-Rel, which also contain transcription activation domains, may mediate B transcription. However, significant differences of these proteins were not detected in the preB cells (data not shown). Second, NF-B may have different posttranslational modifications. Recently, it is shown that phosphorylation and acetylation of p65 can increase NF-B transcriptional activity. Third, ZAS3 may compete for and displace NF-B from B sites. ZAS3 may induce transcription less efficiently than NF-B or may even repress transcription. Members of the ZAS family have been shown to inhibit transcription. ZAS1 negatively regulates the ␣1(II) collagen gene (27) , whereas ZAS2 represses c-myc transcription from the major P2 promoter (28) .
To further elucidate the mechanisms by which ZAS3 regulates B-mediated transcription, B-reporter gene assays were performed with p65 Ϫ/Ϫ MEF. The B-reporter was 5-fold more active in p65
MEFs, demonstrating the importance of p65 in B-mediated transactivation (Fig. 5A) . Notably, even when p65 was absent, B-reporter gene activity was still significantly higher than that of a control reporter, which lacked the B enhancer (data not shown). Therefore, the B reporter must be driven by transacting factors for the MEF, suggesting that ZAS3 also represses B-mediated transcription independent of p65.
ZAS3-dependent transcription was studied by using a heterologous system to differentiate DNA binding from transactivation. Plasmid pSG-ZASC expressed the GAL4 DNAbinding domain fused to the carboxyl one-third of the ZAS3 protein, including an acidic domain. Acidic domains are commonly found in transcription factors and may interact with the basal transcription machinery, transactivators, or adaptor molecules (29) . Another plasmid, pSG-VP16, was similar to pSG-ZASC, except that the ZAS3 sequences were replaced with the transactivation domain of VP16. VP16 is a strong transcriptional activator in mammalian cells (30) . In this study, expression vectors were cotransfected with a reporter plasmid pCMV110, which contains four copies of GAL4-binding sites upstream of the bacterial chloramphenicol acetyl transferase (CAT) gene, into a monkey kidney cell line, Cos-7. Expression of the CAT reporter was induced Ϸ50-fold by pSG-VP16 (Fig.  5B) . Cotransfection with pSG-ZASC repressed the pSG-VP16-mediated transactivation of pCMV110. As a control, the parental vector, pSG424, containing the GAL4 DNA-binding domain alone did not affect transactivation of pCMV110 by pSG-VP16. The data show that ZAS3 inhibits transactivation of VP16 and suggest that ZAS3 may function as a transcriptional repressor.
Previous studies have implicated ZAS in maintaining normal growth. In Drosophila, expression of shn in cyst cells restricts proliferation and mitosis of neighboring germ cells (31) . Similarly, down-regulation of ZAS3 by an antisense construct generally accelerated the growth of cell lines (32) . In HeLa cells, ZAS3 deficiency led to anchorage-independent growth and the formation of multinucleated giant cells, in which nuclear division occurred without cell divisions. Gene knockout experiments further show that ZAS2 and -3 are required for thymocyte maturation (15, 33) . Several developmental anomalies, including tumorigenesis, polydactyly, and hydronephrosis, were observed in ZAS3 (15) . In addition, those mice showed a progressive depletion of CD4 (33) . In addition, ZAS proteins have been implicated in signal transduction. Shn associates with Mad͞Smad to modulate decapentaplegic͞ transforming growth factor ␤ signaling during embryonic development (7). ZAS3 associates with TRAF2 to repress the TNF͞ NF-B signal pathway (8) . Furthermore, changes in gene expression of ZAS genes have been associated with poor prognosis in chronic lymphocytic leukemia patients (34) . We speculate that ZAS3 may have a tumor suppression function.
Here, we have shown that the subcellular localization of p65 and hence the major transactivation activity of NF-B are modulated by ZAS3. A model for ZAS3 to regulate cellular homeostasis is shown in Fig. 6 . We propose that, whereas NF-B activates transcription, ZAS3 mostly represses transcription. In unstimulated cells, ZAS3 is responsible, at least in part, for guarding against aberrant NF-B-mediated transactivation and does so judiciously via multiple checkpoints: by inhibiting the nuclear localization of p65, by competing for cis-acting B gene regulatory elements, and by serving as a transcriptional repressor. In conclusion, this study establishes the groundwork for the ZAS family of zinc-finger proteins as governors of NF-B-mediated cell functions including apoptosis, proliferation, inf lammation, and immunity.
